Today, the contract market is very concentrated,


Funds are grouping around a few high-volume names.
Rank 1 $EDEN +61.1%
Trading volume $691M, Open Interest +49.6%.
The increase in price and volume are expanding together,
Not short pulses without volume.
Rank 2 $PROVE +47.1%
Fee rate -0.175%, OI +651.9%.
Bears are still paying and holding on,
This kind of structure is becoming more promising the longer it drags.
Rank 3 $FIDA +32.5%
Fee rate -0.277%, trading volume $531M.
Negative fee rates are already extreme,
The order book looks like it’s forcing bears to take a stance.
Rank 4 $BSB +29.0%
Depth data not provided, among the top four in gains.
There’s heat but lacking confirmation,
More like an emotion-following market.
Rank 5 $USELESS +26.8%
Depth data not provided, in the top five in gains.
Names are recognizable,
But order book details are still insufficient.
Rank 6 $1000CHEEMS +26.1%
Depth data not provided, gains are ongoing.
More meme-like elasticity,
Need to see if trading can sustain it.
Rank 7 $MITO +22.2%
Depth data not provided, gains over 20%.
Strength is not weak,
But information density is one level lower.
Rank 8 $2Z +21.1%
Depth data not provided, still in the Top 10.
Belongs to a spreading trend,
Not the most core today.
Rank 9 $BEAT +20.2%
Depth data not provided, gains just over 20%.
Has a follow-up flavor,
Order book confirmation is average.
Rank 10 $HYPE +16.5%
Depth data not provided, ranked tenth.
Strength remains,
But not as tense as the top three.
Top 4-10 summary:
BSB +29.0%, USELESS +26.8%,
1000CHEEMS +26.1%, MITO +22.2%,
2Z +21.1%, BEAT +20.2%,
HYPE +16.5%.
Short squeeze candidates:
PROVE and FIDA fees are very extreme,
EDEN has a sudden influx of OI.
Overall, a few tokens are absorbing liquidity,
The continuation depends on EDEN, PROVE, and FIDA.
Generated using Claude Opus 4.7 model.
Claude is AI and can make mistakes. Please double-check responses.
EDEN-0.45%
PROVE30.87%
FIDA16.34%
BSB-12.72%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned